Engenra Biologics Private Limited - Company Profile

It is a business services private limited company based in Seri Lingampally, Telangana, India, established in 2026.
2026 Seri Lingampally, Telangana, India Active
Last Updated:
Access Report
About Engenra Biologics Private Limited

Engenra Biologics Private Limited, a active private limited company, was established on 24 February 2026 in Seri Lingampally, Telangana, India. it holds CIN: U21000TS2026PTC212027. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.

Formerly known as Engenra Biologics Private Limited. Its leadership includes Madan Mohan Reddy Mettu (Director), Satakarni Makkapati (Director), Santhanam Subramanian (Director). It is based at Galaxy, Floors 22-24,, Plot No. 1 Survey No 83/1, Seri Lingampally, Telangana, 500032.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U21000TS2026PTC212027

  • Registration Number

    212027

  • Incorporation Date

    24 February 2026

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹1.00 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 1.00 M
  • Company Age 1 Month 1 Day
Company report

Engenra Biologics Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Engenra Biologics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Engenra Biologics Private Limited?
Current Directors
Name Designation Appointment Date Status
Madan Mohan Reddy Mettu Director 24 Feb 2026 Current
Satakarni Makkapati Director 24 Feb 2026 Current
Santhanam Subramanian Director 24 Feb 2026 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Engenra Biologics.
Engenra Biologics revenue growth over time
Engenra Biologics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Engenra Biologics?

Unlock access to Engenra Biologics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Engenra Biologics?

Unlock and access historical data on people associated with Engenra Biologics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Engenra Biologics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Engenra Biologics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Engenra Biologics
Recent Activity within the Organization
  • Director Appointment

    Progress on Madan Mohan Reddy Mettu was appointed as a Director was appointed as a Director on 24 Feb 2026 & has been associated with this company since 1 month 1 day . was documented.

  • Director Appointment

    Progress on Satakarni Makkapati was appointed as a Director was appointed as a Director on 24 Feb 2026 & has been associated with this company since 1 month 1 day . was documented.

  • Director Appointment

    The activity Santhanam Subramanian was appointed as a Director was appointed as a Director on 24 Feb 2026 & has been associated with this company since 1 month 1 day . was completed.

  • Company Incorporation

    Engenra Biologics Private Limited was registered on 24 Feb 2026 with Roc Hyderabad & aged 1 month 1 day as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Engenra Biologics Private Limited?

The CIN of Engenra Biologics Private Limited is U21000TS2026PTC212027.

Where is Engenra Biologics Private Limited headquartered?

Engenra Biologics Private Limited is headquartered at Galaxy, Floors 22-24,, Plot No. 1 Survey No 83/1, Seri Lingampally, Telangana, 500032.

When was Engenra Biologics Private Limited incorporated?

Engenra Biologics Private Limited was incorporated on 24 February 2026.

Who are the current directors of Engenra Biologics Private Limited?

The current directors of Engenra Biologics Private Limited are

Is Engenra Biologics Private Limited a listed company?

Engenra Biologics Private Limited is unlisted.

What is the capital structure of Engenra Biologics Private Limited?

The authorized capital of Engenra Biologics Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available